Thomas A. Armer is Chief Scientific Officer at MAP Pharmaceuticals, Inc. (MAPP). They have made 2 open-market trades across 1 company since 2009, most recently 2015-01-25.
CIK 0001413824
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MAPP | 130,878 | — |
Shares reported on the most recent Form 4, priced at the 2013-01-29 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MAPP | SELL · 10b5-1 | 2013-01-23 | 2013-01-25 | $24.76 | $1.5M | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2012-02-13 | 2012-02-14 | $15.65 | $529K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2012-02-08 | 2012-02-10 | $16.00 | $419K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2012-02-03 | 2012-02-07 | $15.00 | $300K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2011-12-19 | 2011-12-21 | $14.00 | $280K | N/A | N/A | N/A |
| MAPP | SELL | 2011-03-04 | 2011-03-08 | $16.10 | $483K | N/A | N/A | N/A |
| MAPP | SELL | 2009-12-14 | 2009-12-16 | $9.54 | $95K | N/A | N/A | N/A |
| MAPP | SELL · 10b5-1 | 2009-05-26 | 2009-05-28 | $9.61 | $961K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.